Long-chain Omega-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer

Overview

Journal Nutr Cancer

Publisher Routledge

Specialties Nutritional Sciences
Oncology

Date 2013 Sep 24

PMID 24053119

Citations 38

Authors

Elizabeth D Kantor

Johanna W Lampe

Ulrike Peters

Thomas L Vaughan

Emily White

Affiliations

Soon will be listed here.

Abstract

Research suggests that long-chain omega-3 polyunsaturated fatty acids (LC-PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have antineoplastic properties, yet evidence for association between LC-PUFAs and colorectal cancer (CRC) remains inconsistent. Using the VITamins And Lifestyle (VITAL) cohort, we evaluated how EPA/DHA intake, and its primary sources, fish oil supplement use and dark fish consumption, relate to CRC risk. A total of 68,109 Washington residents aged 50-76 completed a questionnaire between 2000-2002 and were followed for CRC through 2008 (n = 488). Persons using fish oil supplements on 4+ days/wk for 3+ yr experienced 49% lower CRC risk than nonusers (hazard ratio = 0.51, 95% CI = 0.26-1.00; P trend = 0.06). The association between fish oil use and decreased CRC risk was primarily observed for men (P interaction = 0.02; P trend men = 0.02; P trend women = 0.88) and for colon cancer (P difference = 0.05; P trend colon = 0.03; P trend rectum = 0.87). Although dark fish and total EPA + DHA intake were not associated with CRC risk overall, these associations varied by genetic risk (P interaction = 0.009 and 0.02, respectively), with inverse associations observed among low-moderate genetic risk groups and positive associations observed among high risk groups. Results suggest that associations between LC-PUFA intake and CRC may vary by gender, subsite, and genetic risk, providing additional insight into the potential role of LC-PUFAs in cancer prevention.

Citing Articles

Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions.

Ahmad A, Mahmood N, Raza M, Mushtaq Z, Saeed F, Afzaal M Heliyon. 2024; 10(8):e29495.

PMID: 38655310 PMC: 11035079. DOI: 10.1016/j.heliyon.2024.e29495.

A Free Amino Acid Diet Alleviates Colorectal Tumorigenesis through Modulating Gut Microbiota and Metabolites.

Yu Y, Li G, Ren Y, Xu X, Xu Z, Geng Y Nutrients. 2024; 16(7).

PMID: 38613073 PMC: 11013359. DOI: 10.3390/nu16071040.

Fish oil supplement use modifies the relationship between dietary oily fish intake and plasma -3 PUFA levels: an analysis of the UK Biobank.

Aldoori J, Zulyniak M, Toogood G, Hull M Br J Nutr. 2024; 131(9):1608-1618.

PMID: 38220216 PMC: 11043909. DOI: 10.1017/S0007114524000138.

Anti-Inflammatory and Immune Properties of Polyunsaturated Fatty Acids (PUFAs) and Their Impact on Colorectal Cancer (CRC) Prevention and Treatment.

Tojjari A, Choucair K, Sadeghipour A, Saeed A, Saeed A Cancers (Basel). 2023; 15(17).

PMID: 37686570 PMC: 10487099. DOI: 10.3390/cancers15174294.

The effect of FTO gene rs9939609 polymorphism on the association between colorectal cancer and different types of dietary fat intake: a case-control study.

Hajipour A, Hassanpour Ardekanizadeh N, Roumi Z, Shekari S, Aminnezhad Kavkani B, Shalmani S J Physiol Anthropol. 2023; 42(1):17.

PMID: 37543622 PMC: 10404375. DOI: 10.1186/s40101-023-00333-4.

References

Hall M, Campos H, Li H, Sesso H, Stampfer M, Willett W . Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(2):314-21. DOI: 10.1158/1055-9965.EPI-06-0346. View

Balk E, Lichtenstein A, Chung M, Kupelnick B, Chew P, Lau J . Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006; 189(1):19-30. DOI: 10.1016/j.atherosclerosis.2006.02.012. View

Butler L, Wang R, Koh W, Stern M, Yuan J, Yu M . Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int J Cancer. 2008; 124(3):678-86. PMC: 2736597. DOI: 10.1002/ijc.23950. View

Zhao Y, Joshi-Barve S, Barve S, Chen L . Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr. 2004; 23(1):71-8. DOI: 10.1080/07315724.2004.10719345. View

Clarke R, Lund E, Latham P, Pinder A, Johnson I . Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29. Lipids. 2000; 34(12):1287-95. DOI: 10.1007/s11745-999-0480-7. View

Rothwell P, Wilson M, Elwin C, Norrving B, Algra A, Warlow C . Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010; 376(9754):1741-50. DOI: 10.1016/S0140-6736(10)61543-7. View

Wu C, Wang C, Kennedy J . Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther. 2011; 33(11):1749-58. DOI: 10.1016/j.clinthera.2011.09.024. View

Lubbe S, Whiffin N, Chandler I, Broderick P, Houlston R . Relationship between 16 susceptibility loci and colorectal cancer phenotype in 3146 patients. Carcinogenesis. 2011; 33(1):108-12. DOI: 10.1093/carcin/bgr243. View

Habermann N, Ulrich C, Lundgreen A, Makar K, Poole E, Caan B . PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer. Genes Nutr. 2012; 8(1):115-26. PMC: 3534991. DOI: 10.1007/s12263-012-0302-x. View

10.

Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. DOI: 10.3322/caac.20073. View

11.

White E, Patterson R, Kristal A, Thornquist M, King I, Shattuck A . VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol. 2003; 159(1):83-93. DOI: 10.1093/aje/kwh010. View

12.

Fritsche K . Fatty acids as modulators of the immune response. Annu Rev Nutr. 2006; 26:45-73. DOI: 10.1146/annurev.nutr.25.050304.092610. View

13.

Geelen A, Schouten J, Kamphuis C, Stam B, Burema J, Renkema J . Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am J Epidemiol. 2007; 166(10):1116-25. DOI: 10.1093/aje/kwm197. View

14.

Mollard R, Gillam M, Wood T, Taylor C, Weiler H . (n-3) fatty acids reduce the release of prostaglandin E2 from bone but do not affect bone mass in obese (fa/fa) and lean Zucker rats. J Nutr. 2005; 135(3):499-504. DOI: 10.1093/jn/135.3.499. View

15.

Kato I, Majumdar A, Land S, Barnholtz-Sloan J, Severson R . Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer. 2009; 127(4):942-51. PMC: 2891322. DOI: 10.1002/ijc.25103. View

16.

Patterson R, Kristal A, Tinker L, Carter R, Bolton M, Agurs-Collins T . Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999; 9(3):178-87. DOI: 10.1016/s1047-2797(98)00055-6. View

17.

Sczaniecka A, Brasky T, Lampe J, Patterson R, White E . Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort. Nutr Cancer. 2012; 64(8):1131-42. PMC: 3633593. DOI: 10.1080/01635581.2012.718033. View

18.

Courtney E, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, Roda E . Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis. 2007; 22(7):765-76. DOI: 10.1007/s00384-006-0240-4. View

19.

Gerber M . Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr. 2012; 107 Suppl 2:S228-39. DOI: 10.1017/S0007114512001614. View

20.

Latham P, Lund E, Johnson I . Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis. 1999; 20(4):645-50. DOI: 10.1093/carcin/20.4.645. View